Wiggins JM - Search Results

1

Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682,679.

deSolms SJ, Giuliani EA, Guare JP, Vacca JP, Sanders WM, Graham SL, Wiggins JM, Darke PL, Sigal IS, Zugay JA, et al. deSolms SJ, et al. Among authors: wiggins jm. J Med Chem. 1991 Sep;34(9):2852-7. doi: 10.1021/jm00113a025. J Med Chem. 1991. PMID: 1910089

2

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. Trans-6-[2-(substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones.

Prugh JD, Alberts AW, Deana AA, Gilfillian JL, Huff JW, Smith RL, Wiggins JM. Prugh JD, et al. Among authors: wiggins jm. J Med Chem. 1990 Feb;33(2):758-65. doi: 10.1021/jm00164a047. J Med Chem. 1990. PMID: 2299642

3

Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses.

Wang LL, Estrada L, Wiggins J, Anantpadma M, Patten JJ, Davey RA, Xiang SH. Wang LL, et al. Antiviral Res. 2022 Oct;206:105399. doi: 10.1016/j.antiviral.2022.105399. Epub 2022 Aug 22. Antiviral Res. 2022. PMID: 36007601

4

Analysis of organic volatile impurities in pharmaceutical excipients by static headspace capillary gas chromatography.

Fliszar K, Wiggins JM, Pignoli CM, Martin GP, Li Z. Fliszar K, et al. Among authors: wiggins jm. J Chromatogr A. 2004 Feb 20;1027(1-2):83-91. doi: 10.1016/j.chroma.2003.08.086. J Chromatogr A. 2004. PMID: 14971487

5

On physicians and litigation.

Merrill RE, Wiggins J. Merrill RE, et al. J Okla State Med Assoc. 1991 Apr;84(4):165-9. J Okla State Med Assoc. 1991. PMID: 1870025

6

Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses.

Bowder D, Hollingsead H, Durst K, Hu D, Wei W, Wiggins J, Medjahed H, Finzi A, Sodroski J, Xiang SH. Bowder D, et al. Virology. 2018 Aug;521:158-168. doi: 10.1016/j.virol.2018.06.005. Epub 2018 Jun 21. Virology. 2018. PMID: 29936340 Free PMC article.

7

The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.

Lu W, Chen S, Yu J, Behrens R, Wiggins J, Sherer N, Liu SL, Xiong Y, Xiang SH, Wu L. Lu W, et al. J Virol. 2019 Mar 21;93(7):e02128-18. doi: 10.1128/JVI.02128-18. Print 2019 Apr 1. J Virol. 2019. PMID: 30651369 Free PMC article.

8

Blocking HIV-1 Infection by Chromosomal Integrative Expression of Human CD4 on the Surface of Lactobacillus acidophilus ATCC 4356.

Wei W, Wiggins J, Hu D, Vrbanac V, Bowder D, Mellon M, Tager A, Sodroski J, Xiang SH. Wei W, et al. J Virol. 2019 Apr 3;93(8):e01830-18. doi: 10.1128/JVI.01830-18. Print 2019 Apr 15. J Virol. 2019. PMID: 30728264 Free PMC article.

9

Cell-Free DNA in Dermatology Research.

Wiggins JM, Ali S, Polsky D. Wiggins JM, et al. J Invest Dermatol. 2022 Jun;142(6):1523-1528.e1. doi: 10.1016/j.jid.2022.02.021. J Invest Dermatol. 2022. PMID: 35598899 Free PMC article.

10

Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort.

Chang GA, Robinson E, Wiggins JM, Zhang Y, Tadepalli JS, Schafer CN, Darvishian F, Berman RS, Shapiro R, Shao Y, Osman I, Polsky D. Chang GA, et al. Among authors: wiggins jm. J Invest Dermatol. 2022 Oct;142(10):2733-2743.e9. doi: 10.1016/j.jid.2022.03.031. Epub 2022 Apr 22. J Invest Dermatol. 2022. PMID: 35469904 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters